Guardant Health, Inc. (GH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 12.81B |
| Enterprise Value | 14.14B |
| P/E Ratio | -42.21 |
| PEG Ratio | 3.19 |
| Price/Sales Ratio | 16.3 |
| Price/Book Ratio | -75.69 |
| Enterprise/Revenue | 16.82 |
| Enterprise/EBITDA | -48.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.38 |
| Operating Margin | -0.39 |
| Return On Assets | -0.26 |
| Return On Equity | 2.49 |
| Revenue | 982.02M |
| Revenue/Share | 9.51 |
| Gross Profit | 633.01M |
| EBITDA | -373.91M |
| Net Income | -416.28M |
| Diluted EPS | -3.32 |
| Total Cash | 1.03B |
| Total Cash/Share | 7.64 |
| Total Debt | 1.69B |
| Total Debt/Equity | -6.13 |
| Current Ratio | 3.6 |
| Book Value Per Share | -2.05 |
| 52-Week Change | 58.65 |
| 52-Week High | 191.05 |
| 52-Week Low | 74.55 |
| Moving Average 50 Days | 169.26 |
| Moving Average 200 Days | 131.95 |
| Average Volume | 2.01M |
| Shares Outstanding | 134.2M |
| % Held by Institutions | 102.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |